Autopsy report · NCT00278434

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

“Accrual was insufficient to meet study endpoints”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months after it had already started.
• Ran for about 3 years 3 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Cervical Cancer; Precancerous Condition

Interventions

Zoledronate; Placebo (Saline)

Participants

12

Sites

1

Countries

United States

Trials that died the same way

• Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
  “Study stopped due to lack of accrual” (80% match in meaning)
• Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
  “Study was halted for lack of accrual” (80% match in meaning)
• Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer
  “Study never moved forward due to no accrual” (77% match in meaning)
• High Dose Rate Brachyablation of Primary Liver Lesions
  “Study was closed due to poor accrual” (75% match in meaning)
• Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
  “Study was terminated due to lack of accrual” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.